![PDF] Antiarrhythmic properties of novel antianginal drugs in dog and human cardiac preparations | Semantic Scholar PDF] Antiarrhythmic properties of novel antianginal drugs in dog and human cardiac preparations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/99107a3dfda40e116fdacc54b764432eae6f6a52/10-Table1-1.png)
PDF] Antiarrhythmic properties of novel antianginal drugs in dog and human cardiac preparations | Semantic Scholar
![PDF] Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment | Semantic Scholar PDF] Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e78747c86eb151b338b3303d7ae5e38c3d0e24f/4-Table1-1.png)
PDF] Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment | Semantic Scholar
![Possible combinations of different classes of antianginal drugs. The... | Download Scientific Diagram Possible combinations of different classes of antianginal drugs. The... | Download Scientific Diagram](https://www.researchgate.net/publication/319549129/figure/fig1/AS:614181757796363@1523443750157/Possible-combinations-of-different-classes-of-antianginal-drugs-The-schematic-shows.png)
Possible combinations of different classes of antianginal drugs. The... | Download Scientific Diagram
![Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials - Clinical Therapeutics Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d366a690-c6bf-468e-83e7-3b0394aba128/gr1_lrg.jpg)
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials - Clinical Therapeutics
![Table 1: Second- and Third-line Anti-anginal Medication (Above Beta-blockers and Calcium Channel Antagonists) | Radcliffe Cardiology Table 1: Second- and Third-line Anti-anginal Medication (Above Beta-blockers and Calcium Channel Antagonists) | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/Table-1-Second-and-Third-line-Anti-anginal-Medication.png)